Optimal bone mechanical and material properties require a functional glucagon-like peptide-1 receptor
about
New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disordersThe alliance of mesenchymal stem cells, bone, and diabetesGlucagon-like peptide-1 receptor agonist Liraglutide has anabolic bone effects in ovariectomized rats without diabetesThe Impact of Glucagon-Like Peptide-1 on Bone Metabolism and Its Possible Mechanisms.Dipeptidyl Peptidase-4 and Adolescent Idiopathic Scoliosis: Expression in Osteoblasts.Glucagon-like peptide-1(GLP-1) receptor agonists: potential to reduce fracture risk in diabetic patients?Risk of bone fractures associated with glucagon-like peptide-1 receptor agonists' treatment: a meta-analysis of randomized controlled trials.GLP-1: benefits beyond pancreas.Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review.Diabetes Drug Effects on the Skeleton.Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice.Effect of Dipeptidyl Peptidase-4 Inhibitors on Bone Metabolism and the Possible Underlying Mechanisms.Comparison between quantitative X-ray imaging, dual energy X-ray absorptiometry and microCT in the assessment of bone mineral density in disuse-induced bone loss.Use of GLP-1 mimetic in type 2 diabetes mellitus: is it the end of fragility fractures?Exenatide Improves Bone Quality in a Murine Model of Genetically Inherited Type 2 Diabetes Mellitus.Intestinal Incretins and the Regulation of Bone Physiology.The bone-preserving effects of exendin-4 in ovariectomized rats.Structure and Function of Bone Marrow Adipocytes.Stable Incretin Mimetics Counter Rapid Deterioration of Bone Quality in Type 1 Diabetes Mellitus.Use of glucagon-like peptide-1 receptor agonists and bone fractures: a meta-analysis of randomized clinical trials.
P2860
Q26777654-FD6DE07C-CB21-474F-9A7F-6F55E6CF236EQ27012497-97ED51CF-E2CC-4A13-8970-17F578EE5F01Q28546539-50354CD8-F03C-44BC-A884-77B74DAC4A61Q33627749-867F9E28-27CD-4481-81E5-25B7B1D2E752Q33784648-41F59673-2B85-4E39-B240-1628825F64DDQ36410243-95F4A145-1ADC-48B0-8EA6-FEBECEBF67DDQ38235219-3E43300E-F44B-4DBC-8D1B-EBE9426BE6F6Q38238288-22ABBA59-89D6-44A5-BA38-AC53293BB809Q38441017-BCFBC6D6-C012-4049-BCBA-B83953B04D65Q38999214-5A2FCCCB-A2F7-4356-94B1-891B8C371A3BQ39345729-20BCED85-5F01-48D6-A3E0-D180F4C76DFFQ41108574-F64E4A6E-C1F9-408A-9313-63EAED23D979Q41934854-51555A39-F8E8-42DD-B9E6-3F39A871F837Q44475967-022FCA18-3451-42EE-80AC-E641E663870CQ47147079-38F869E9-B22A-4D40-80C4-6EE28A91A797Q50171023-9D6DAA67-C873-49DA-8F7C-6FC6A4BAB326Q51012841-AE4C8FA9-3E3D-4C1F-9338-119AEA6F3DC6Q52709053-20CBBB48-B6F0-44D2-8140-5CA3184324FFQ53841357-BC8A8895-549E-4528-88F6-4D8546055567Q54687755-961BEC3D-8FC5-4723-BF88-0E1899526756
P2860
Optimal bone mechanical and material properties require a functional glucagon-like peptide-1 receptor
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Optimal bone mechanical and ma ...... ucagon-like peptide-1 receptor
@ast
Optimal bone mechanical and ma ...... ucagon-like peptide-1 receptor
@en
Optimal bone mechanical and ma ...... ucagon-like peptide-1 receptor
@nl
type
label
Optimal bone mechanical and ma ...... ucagon-like peptide-1 receptor
@ast
Optimal bone mechanical and ma ...... ucagon-like peptide-1 receptor
@en
Optimal bone mechanical and ma ...... ucagon-like peptide-1 receptor
@nl
prefLabel
Optimal bone mechanical and ma ...... ucagon-like peptide-1 receptor
@ast
Optimal bone mechanical and ma ...... ucagon-like peptide-1 receptor
@en
Optimal bone mechanical and ma ...... ucagon-like peptide-1 receptor
@nl
P50
P356
P1476
Optimal bone mechanical and ma ...... ucagon-like peptide-1 receptor
@en
P2093
Aleksandra Mieczkowska
Daniel Chappard
P356
10.1530/JOE-13-0146
P407
P577
2013-09-06T00:00:00Z